中石化(00386.HK)全國首個甲醇製氫加氫一體站投用
中石化(00386.HK)旗下中石化燃料油銷售公司的大連盛港油氣氫電服綜合加能站,將成為全國首個甲醇製氫加氫一體站投用。該加能站每日可產出1,000公斤高純度氫氣,相比加氫站傳統用氫方式成本可降低20%以上,而站內甲醇制氫加氫裝置產氫能力為每小時500標準立方米,採用撬塊化建站模式建設,場地利用率為全國最高,主體裝置佔地64平方米,料將成為中國低成本加氫站的示範樣本。
中石化燃料油執行董事楊軍澤表示,製氫加氫一體站正式運作,將為中國氫能產業跨越式發展,提供安全可靠、綠色智能、集約高效的「石化方案」,相信對降低氫氣成本及大規模推廣應用具有積極貢獻。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.